These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 14068044)
1. EFFECT OF ALPHA-METHYL DOPA AND RESERPINE IN HUNTINGTON'S CHOREA, PARKINSON'S DISEASE AND OTHER MOVEMENT DISORDERS. MARKHAM CH; CLARK WG; WINTERS WD Life Sci (1962); 1963 Sep; 9():697-705. PubMed ID: 14068044 [No Abstract] [Full Text] [Related]
2. ANESTHETIC MANAGEMENT FOR BASAL GANGLIA SURGERY IN PATIENTS WITH MOVEMENT DISORDERS. STEEN SN Anesth Analg; 1965; 44():66-9. PubMed ID: 14264817 [No Abstract] [Full Text] [Related]
3. Chapter 33: the history of movement disorders. Lanska DJ Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136 [TBL] [Abstract][Full Text] [Related]
4. Clinical diagnosis of the dyskinesias. Duvoisin R Med Clin North Am; 1972 Nov; 56(6):1321-41. PubMed ID: 4263866 [No Abstract] [Full Text] [Related]
10. FINGERPRINT PATTERNS IN HUNTINGTON'S CHOREA AND PARKINSON'S DISEASE. BARBEAU A; TRUDEAU JG; COITEUX C Can Med Assoc J; 1965 Mar; 92(10):514-6. PubMed ID: 14275039 [TBL] [Abstract][Full Text] [Related]
11. [ON THE CONTROL OF AKINESIA AND OTHER EXTRAPYRAMIDAL MOTOR DISORDERS WITH L-DOPA (L-DIHYDROXYPHENYLALANINE)]. HIRSCHMANN J; MAYER K Dtsch Med Wochenschr; 1964 Oct; 89():1877-80. PubMed ID: 14211843 [No Abstract] [Full Text] [Related]
12. The role of the cerebellar nuclei in dyskinetic disorders. Heimburger RF Confin Neurol; 1969; 31(1):57-69. PubMed ID: 4242638 [No Abstract] [Full Text] [Related]
13. Alleviation of dystonia musculorum deformans and other involuntary movement disorders of childhood by chemopallidectomy and chemopallido-thalamectomy. COOPER IS; BRAVO GJ Clin Neurosurg; 1957-1958; 5():127-49. PubMed ID: 13597141 [No Abstract] [Full Text] [Related]
14. The placement of stereotaxic lesions for involuntary movements other than in Parkinson's disease. Andrew J; Edwards JM; Rudolf Nde M Acta Neurochir (Wien); 1974; Suppl 21():39-47. PubMed ID: 4278333 [No Abstract] [Full Text] [Related]
15. [THE TREATMENT OF EXTRAPYRAMIDAL HYPERKINESIAS WITH SPECIAL REFERENCE TO HUNTINGTON'S CHOREA]. SATTES H; HASE E Psychiatr Neurol Neurochir; 1964; 67():289-98. PubMed ID: 14168888 [No Abstract] [Full Text] [Related]
16. CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders. Davidson DL; Yates CM; Mawdsley C; Pullar IA; Wilson H J Neurol Neurosurg Psychiatry; 1977 Dec; 40(12):1136-41. PubMed ID: 591981 [TBL] [Abstract][Full Text] [Related]
17. Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia. Lindvall B; Olsson JE Adv Neurol; 1990; 53():117-22. PubMed ID: 1700581 [No Abstract] [Full Text] [Related]
18. Sex and gender differences in movement disorders: Parkinson's disease, essential tremor, dystonia and chorea. Arabia G; De Martino A; Moro E Int Rev Neurobiol; 2022; 164():101-128. PubMed ID: 36038202 [TBL] [Abstract][Full Text] [Related]
19. [APROPOS OF THE CLASSIFICATION AND PATHOGENESIS OF HYPERKINESIAS]. PETELIN LS Zh Nevropatol Psikhiatr Im S S Korsakova; 1965; 65():179-86. PubMed ID: 14270050 [No Abstract] [Full Text] [Related]
20. Models of hyperkinetic disorders in primates. Bezard E J Neurosci Methods; 2020 Feb; 332():108551. PubMed ID: 31857131 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]